Neko vs Insurance-Funded Checkups

This is the core adoption ceiling on Neko’s consumer model, because the product has to feel meaningfully better than a free annual checkup, not just more high tech. Neko charges cash, does not bill insurance, and positions the scan as a one hour preventive visit that can be shared with a primary care doctor and followed by outside referrals. That makes it easiest to sell to people who feel underserved by routine care, and harder to sell to patients who already trust their doctor and get covered preventive visits.1 2 3 4 5

• Neko is complementary rather than comprehensive. It measures skin, cardiovascular markers, blood biomarkers, and body data in one visit, but it is not a primary care provider and sends follow up into the existing medical system. For many insured patients, that can look like paying $499 to start a process their doctor already coordinates.1 2 3 4
• The strongest comparison is Function Health. Function also began at $499 for a cash pay preventive membership built around lab work and clinician interpretation, then cut pricing to $365 while arguing that a normal physical covers far fewer biomarkers. That shows how quickly this category gets pulled into a value for money fight against standard insured care.6 7
• This risk is partly demographic. Premium preventive services tend to land first with wellness heavy, affluent users who want extra data and convenience. Moving beyond that early market requires proving that the scan finds useful issues faster, bundles more steps into one visit, and saves enough time or anxiety to justify paying out of pocket on top of insurance.5 8 9

Going forward, Neko’s expansion depends on turning the scan from an interesting extra into a new front door for prevention. The more it can show repeatable detection, cleaner handoffs to physicians, and a noticeably better patient experience than the annual physical, the more $499 starts to look additive instead of redundant.2 3 5